FASEB JOURNAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2024-04-07 MedSci_007 来自吉林省

请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？

5 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2023-12-06 maitianli 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：分子生物学
经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。

23 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2021-04-03 Pentazocine

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。#肿瘤#

124 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2024-03-12 ms8000001041161059 来自上海

Quality control failed什么意思

10 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2024-01-19 tears1115 来自河北省

偏重的研究方向：心血管
经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？

24 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2024-02-28 ms5000000637237821 来自湖北省

请问这个杂志一般with editor会要多久呀？

15 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2020-03-15 轩儿_8286

投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？

131 25

展开25条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2023-09-19 ms8000001515149075 来自湖南省

审稿速度:6.0 | 投稿命中率:75.0
经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。

33 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2024-01-12 ms6083841171193720 来自重庆

请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志

21 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197289, encodeId=40dc219e28940, content=请教大家，这个杂志需要审稿费？选择传统订阅模式也需要交钱（大约2万）？是这么个情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sun Apr 07 20:23:24 CST 2024, time=2024-04-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2173299, encodeId=5f5921e329974, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：文章多次投稿，从8分降低到5分。这个编辑和审稿人似乎很喜欢我们的研究，小修后直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61f71619508, createdName=maitianli, createdTime=Wed Dec 06 16:26:12 CST 2023, time=2023-12-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=953548, encodeId=586d953548ea, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇综述。 1.10提交初稿，1.13送外审，1.29大修。 3.6修回，3.22考虑接收，需要回答问题。 3.23修回，4.2接收。审稿时间很快，一审19天，二审18天。审稿人要求也比较多，提出了很多建设性的意见。<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210403/f017d7d699444ff4abe4fc7232cef638/51b3d85a07144e63af66cf0f50cf6a7f.jpg, createdBy=23665473987, createdName=Pentazocine, createdTime=Sat Apr 03 15:26:51 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192857, encodeId=e5ec219285e2b, content=Quality control failed什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c748666193, createdName=ms8000001041161059, createdTime=Tue Mar 12 22:07:20 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2182586, encodeId=0ce521825863f, content=偏重的研究方向：心血管 经验分享：请问大家，目前状态Quality control check underway，然后收到关于sciscore的邮件了，需要做什么修改吗？还是等待送审之类的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:37:29 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2189866, encodeId=43ba218986689, content=请问这个杂志一般with editor会要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b5e6554517, createdName=ms5000000637237821, createdTime=Wed Feb 28 11:55:19 CST 2024, time=2024-02-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158436, encodeId=f656215843611, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了一篇综述历时约5个月，中间小修了一下，选的传统订阅模式，校稿后顺利online了，可大约两个星期后收到了invoice，2940刀，查了一下官网好像确实需要交版面费，还是被公众号忽悠了，以为免版面费才投的。影响因子还降到5分以下了。开始怀疑是骗子邮箱，但是地址和其他信息好像是对的，找不到证据，过几天准备去交钱了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e865679621, createdName=ms8000001515149075, createdTime=Tue Sep 19 10:18:17 CST 2023, time=2023-09-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2180918, encodeId=b0da218091880, content=请问怎么发撤稿邮件呢？刚投，打算撤回投别的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/dZj08ckjV0K1emuaDxP7GwunLBGOHmLrgEQd6ib23EolmFyLPDyicSW6eR1js16VGWjKckl9SE9pJeKicAfc85CQA/132, createdBy=09b92440859, createdName=ms6083841171193720, createdTime=Fri Jan 12 08:35:07 CST 2024, time=2024-01-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省)]

2024-01-19 ms6000001226293924 来自河北省

偏重的研究方向：心血管
经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？

22 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务